Grażyna K.
- Country
- Poland
- Department
- Oddział Onkologii i Hematologii Dziecięcej
Research Overview
- Phase 3 Study of Imatinib with Cytotoxic Chemotherapy in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Evaluation of Dexamethasone Versus Prednisone in Induction Therapy for Pediatric and Adolescent Lymphoblastic Lymphoma: A Randomized Controlled Trial
- Evaluation of Ruxolitinib Combined with AIEOP-BFM 2017 Chemotherapy in Pediatric Acute Lymphoblastic Leukemia with JAK/STAT Pathway Activation
Data & Insights
Has run more than one trial at 120 of 208 partner sites.
Specializations
Leukemia Research
The investigator specializes in treating acute lymphoblastic leukemia, with particular focus on Philadelphia chromosome-positive ALL in pediatric populations.
- Standard and high-risk ALL treatment protocols
- Targeted therapy approaches
- Pediatric leukemia management
Their work encompasses innovative treatment strategies combining chemotherapy with targeted therapeutic agents.
Lymphoma Studies
The investigator conducts research in lymphoblastic lymphoma, focusing on developing optimized treatment protocols for children and adolescents.
- Central nervous system disease management
- Risk-stratified treatment approaches
- Treatment intensification strategies
Their research includes evaluation of various therapeutic combinations for different risk groups.
Therapeutic Innovation
The investigator explores novel therapeutic approaches including JAK/STAT pathway targeting and immunotherapy strategies.
- Molecular pathway inhibition
- Response-adapted therapy
- Treatment protocol optimization
Their work integrates innovative therapeutic agents with established treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.